The recent judgment in Amgen v Sanofi by the United States Supreme Court has generated significant attention within the legal and patent... Read More »

Most of the community involved in life science litigation and pharmaceutical companies, thought they saw the end of the long-fought battle ... Read More »

MMUNEX CORPORATION v. SANOFI-AVENTIS U.S. LLC Before Prost, Reyna, and Taranto.  Appeal from the Patent Trial and Appeal Board. Summary: Expiration of a... Read More »

Earlier this month, we released our 2nd Annual Patent Prosecution Intelligence Report where we ranked the top patent firms based on their activity and performance... Read More »

SANOFI-AVENTIS U.S., LLC v. FRESENIUS KABI USA, LLC Before Lourie, Moore, and Taranto.  Appeal from the United States District Court for the District of New... Read More »

Federal Circuit Summaries Before PROST, WALLACH, and TARANTO.  Appeal from the District of Delaware Summary: (1) A party may not avoid inducement based... Read More »

In Sanofi v. Watson Labs., the Circuit affirms a determination of induced infringement of one patent and direct infringement of another, thus assuring Sanofi another... Read More »

In Amgen, Inc. v. Sanofi, Appeal no. 2017-1480 (Fed. Cir., Oct. 5, 2017) the Fed. Cir. panel reversed the district court’s finding that Amgen antibody patents... Read More »